Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1594

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    PS01 - Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)

    • Type: Plenary
    • Track: N.A.
    • +

      PS01.01 - Welcome Video

      07:00 - 07:02

      • Abstract

      Abstract not provided

    • +

      PS01.02 - National Lung Cancer Screening Program in Taiwan: The TALENT Study

      07:02 - 07:12  |  Presenting Author(s): Pan-Chyr Yang

      • Abstract

      The abstract for this presentation is currently under embargo or has not been submitted.

    • +

      PS01.03 - Discussant

      07:12 - 07:20  |  Presenting Author(s): Ugo Pastorino

      • Abstract

      Abstract not provided

    • +

      PS01.04 - International Tailored Chemotherapy Adjuvant Trial : ITACA Trial. Final Results

      07:20 - 07:30  |  Presenting Author(s): Silvia Novello

      • Abstract

      The abstract for this presentation is currently under embargo or has not been submitted.

    • +

      PS01.05 - Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB–IIIB NSCLC: LCMC3 Trial Primary Analysis

      07:30 - 07:40  |  Presenting Author(s): Jay M. Lee

      • Abstract

      The abstract for this presentation is currently under embargo or has not been submitted.

    • +

      PS01.06 - Discussant

      07:40 - 07:50  |  Presenting Author(s): Shinichi Toyooka

      • Abstract

      Abstract not provided

    • +

      PS01.07 - CodeBreaK 100: Registrational Phase 2 Trial of Sotorasib in KRAS p.G12C Mutated Non-small Cell Lung Cancer

      07:50 - 08:00  |  Presenting Author(s): Bob T. Li

      • Abstract

      The abstract for this presentation is currently under embargo or has not been submitted.

    • +

      PS01.08 - Discussant

      08:00 - 08:08  |  Presenting Author(s): Pasi Antero Jänne

      • Abstract

      Abstract not provided

    • +

      PS01.09 - Pembrolizumab Plus Ipilimumab vs Pembrolizumab Plus Placebo as 1L Therapy for Metastatic NSCLC of PD-L1 TPS ≥50%: KEYNOTE-598

      08:08 - 08:18  |  Presenting Author(s): Michael Boyer

      • Abstract

      The abstract for this presentation is currently under embargo or has not been submitted.

    • +

      PS01.10 - Discussant

      08:18 - 08:26  |  Presenting Author(s): Yun Fan

      • Abstract

      Abstract not provided

    • +

      PS01.11 - Nivolumab Versus Placebo in Relapsed Malignant Mesothelioma: The CONFIRM Phase 3 Trial

      08:26 - 08:36  |  Presenting Author(s): Dean Fennell

      • Abstract

      The abstract for this presentation is currently under embargo or has not been submitted.

    • +

      PS01.12 - Discussant

      08:36 - 08:44  |  Presenting Author(s): Rina Hui

      • Abstract

      Abstract not provided

    • +

      PS01.13 - Live Q&A

      08:44 - 09:00

      • Abstract

      Abstract not provided

  • +

    ES09 - Biomarkers in Immunotherapy

    • Type: Educational Session
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • +

      ES09.01 - Chair

      09:15 - 09:15  |  Presenting Author(s): Katerina Politi

      • Abstract

      Abstract not provided

    • +

      ES09.02 - Chair

      09:15 - 09:15  |  Presenting Author(s): Melina Elpi Marmarelis

      • Abstract

      Abstract not provided

    • +

      ES09.03 - Role of PD-L1 and Tumor Mutational Burden in NSCLC Immunotherapy

      09:15 - 09:25  |  Presenting Author(s): Solange Peters

      • Abstract

      Loading...

    • +

      ES09.04 - Individual Genomic Alterations as Predictive Factors for NSCLC Immunotherapy

      09:25 - 09:35  |  Presenting Author(s): Ferdinandos Skoulidis

      • Abstract

      Abstract not provided

    • +

      ES09.05 - Blood-based Biomarkers for Immunotherapy: Applications and Limitations

      09:35 - 09:45  |  Presenting Author(s): Lizza Hendriks

      • Abstract

      Loading...

    • +

      ES09.06 - Immune Contexture and Immunotherapy Response in NSCLC

      09:45 - 09:55  |  Presenting Author(s): Kurt Alex Schalper

      • Abstract

      Abstract not provided

    • +

      ES09.07 - Immunotherapy Biomarkers in NSCLC: Looking into the Future

      09:55 - 10:05  |  Presenting Author(s): Vamsidhar Velcheti

      • Abstract

      Abstract not provided

    • +

      ES09.08 - Live Q&A

      10:05 - 10:15

      • Abstract

      Abstract not provided

  • +

    ES10 - Advances in Lung Cancer Screening Through Imaging and Data Analytics

    • Type: Educational Session
    • Track: Screening and Early Detection
    • +

      ES10.01 - Chair

      09:15 - 09:15  |  Presenting Author(s): Charlene J Liew

      • Abstract

      Abstract not provided

    • +

      ES10.02 - Chair

      09:15 - 09:15  |  Presenting Author(s): Yeol Kim

      • Abstract

      Abstract not provided

    • +

      ES10.03 - AI-Enabled Lung Cancer Predictive Analytics - The Future of Lung Cancer Screening?

      09:15 - 09:27  |  Presenting Author(s): Zaiyi Liu

      • Abstract

      Abstract not provided

    • +

      ES10.05 - Size Isn't Everything - Other High-Risk CT Imaging Features

      09:27 - 09:39  |  Presenting Author(s): Heber MacMahon

      • Abstract

      Abstract not provided

    • +

      ES10.06 - Putting It Together: Current Best Practices in the Evaluation and Follow-Up of the Indeterminate Pulmonary Nodule

      09:39 - 09:51  |  Presenting Author(s): David Raymond Baldwin

      • Abstract

      Loading...

    • +

      ES10.07 - Live Q&A

      09:51 - 10:15

      • Abstract

      Abstract not provided

  • +

    ES11 - Practice Changing Initiatives

    • Type: Educational Session
    • Track: Nursing and Allied Health Professionals
    • +

      ES11.01 - Chair

      09:15 - 09:15  |  Presenting Author(s): Maria Ftanou

      • Abstract

      Abstract not provided

    • +

      ES11.02 - Chair

      09:15 - 09:15  |  Presenting Author(s): Anne Fraser

      • Abstract

      Abstract not provided

    • +

      ES11.03 - Managing the Psychological Needs of Patients in a Screening Service

      09:15 - 09:27  |  Presenting Author(s): Lisa Burgess

      • Abstract

      Loading...

    • +

      ES11.04 - Assessment of Physical Function in Patients Undergoing Lung-sparing Surgery for Malignant Pleural Mesothelioma

      09:27 - 09:39  |  Presenting Author(s): Simon Ho

      • Abstract

      Loading...

    • +

      ES11.05 - Effect of Qigong on Symptom Management of Lung Cancer Patients

      09:39 - 09:51  |  Presenting Author(s): Shirley Siu-yin Ching

      • Abstract

      Abstract not provided

    • +

      ES11.06 - Developing a Care Board

      09:51 - 10:03  |  Presenting Author(s): Manuela Eicher

      • Abstract

      Loading...

    • +

      ES11.07 - Preoperative Exercise Training for Patients with Non-Small Cell Lung Cancer

      10:03 - 10:18  |  Presenting Author(s): Catherine Granger

      • Abstract

      Abstract not provided

    • +

      ES11.08 - Live Q&A

      10:18 - 10:43

      • Abstract

      Abstract not provided

  • +

    ES12 - Public Health Issues in Lung Cancer Screening

    • Type: Educational Session
    • Track: Screening and Early Detection
    • +

      ES12.01 - Patient Perspective on Lung Cancer Screening and Health Disparities

      10:30 - 10:45  |  Presenting Author(s): Andrea Borondy-Kitts

      • Abstract

      Loading...

    • +

      ES12.02 - Defining High Risk

      10:45 - 11:00  |  Presenting Author(s): Martin Carl Tammemagi

      • Abstract

      Loading...

    • +

      ES12.03 - Screening in Indigenous Maori Population

      11:00 - 11:15  |  Presenting Author(s): Sue Crengle

      • Abstract

      Abstract not provided

    • +

      ES12.04 - Mobile CT and Effective Screening for Underserved Populations

      11:15 - 11:30  |  Presenting Author(s): Carlijn van der Aalst

      • Abstract

      Abstract not provided

  • +

    OA07 - Immuno-biology and Novel Immunotherapeutics from Bench to Bed

    • Type: Oral
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • +

      OA07.01 - Chair

      10:30 - 10:30  |  Presenting Author(s): Jyoti D Patel

      • Abstract

      Abstract not provided

    • +

      OA07.02 - Chair

      10:30 - 10:30  |  Presenting Author(s): Aaron Lisberg

      • Abstract

      Abstract not provided

    • +

      OA07.03 - Comutations in DDR Pathways Predict Atezolizumab Response in Non-Small Cell Lung Cancer Patients

      10:30 - 10:40  |  Presenting Author(s): Wei Nie

      • Abstract

      Loading...

    • +

      OA07.04 - LKB1 Deficiency Leads to an “Adenosine-Rich” Tumor Microenvironment by Recruiting Myeloid-Derived Suppressive Cells

      10:40 - 10:50  |  Presenting Author(s): Xue Bai

      • Abstract

      Loading...

    • +

      OA07.05 - Discussant

      10:50 - 10:55  |  Presenting Author(s): Myung-Ju Ahn

      • Abstract

      Abstract not provided

    • +

      OA07.06 - Interdependence of KRAS and TP53 Mutations in Predicting ICI Efficacy in EGFR/ALKWT Non-Squamous NSCLC: Results From 1129 Patient-Level Data

      10:55 - 11:00  |  Presenting Author(s): Lin Li

      • Abstract

      Loading...

    • +

      OA07.07 - PARP1 Inhibitors Enhanced IFNγ-Induced PD-L1 Expression in LKB1-Mutant Lung Cancer

      11:00 - 11:05  |  Presenting Author(s): Xue Bai

      • Abstract

      Loading...

    • +

      OA07.08 - HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed, Phase II Platform Study in Patients with NSCLC, who Progressed on Anti-PD(L)1 Therapy  

      11:05 - 11:10  |  Presenting Author(s): Benjamin Besse

      • Abstract

      Loading...

    • +

      OA07.09 - Sintilimab in Combination with Anlotinib as First-Line Therapy for Advanced NSCLC: Final Analysis of Primary Endpoints

      11:10 - 11:15  |  Presenting Author(s): Baohui Han

      • Abstract

      The abstract for this presentation is currently under embargo or has not been submitted.

    • +

      OA07.10 - Discussant

      11:15 - 11:20  |  Presenting Author(s): Laura Mezquita

      • Abstract

      Abstract not provided

    • +

      OA07.11 - Live Q&A

      11:20 - 11:30

      • Abstract

      Abstract not provided

  • +

    ES14 - Novel Immunotherapy Strategies in NSCLC

    • Type: Educational Session
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • +

      ES14.02 - Cellular Therapies in NSCLC

      11:45 - 11:57  |  Presenting Author(s): Melissa L Johnson

      • Abstract

      Loading...

    • +

      ES14.03 - Combining Epigenetic Therapy and Immunotherapy in NSCLC

      11:57 - 12:09  |  Presenting Author(s): Julie Brahmer

      • Abstract

      Abstract not provided

    • +

      ES14.04 - Combining Immunotherapy and Anti-Angiogenic Agents

      12:09 - 12:21  |  Presenting Author(s): Enriqueta Felip

      • Abstract

      Abstract not provided

    • +

      ES14.05 - Combining Targeted Therapies With Immunotherapy

      12:21 - 12:33  |  Presenting Author(s): Daniel SW Tan

      • Abstract

      Abstract not provided

    • +

      ES14.06 - Novel Immunotherapy Targets in NSCLC

      12:33 - 12:45  |  Presenting Author(s): Jie Wang

      • Abstract

      Abstract not provided

  • +

    MA05 - Lung Cancer Screening

    • Type: Mini Oral
    • Track: Screening and Early Detection
    • +

      MA05.01 - Chair

      11:45 - 11:45  |  Presenting Author(s): Chong Kin Liam

      • Abstract

      Abstract not provided

    • +

      MA05.02 - Chair

      11:45 - 11:45  |  Presenting Author(s): Jacob Sands

      • Abstract

      Abstract not provided

    • +

      MA05.03 - Differential Frequency of Blood Immune Cells as Biomarkers for Risks Assessment in bioMILD Lung Cancer Screening Trial

      11:45 - 11:50  |  Presenting Author(s): Gabriella Sozzi

      • Abstract

      Loading...

    • +

      MA05.04 - Why are Lung Cancer Detection Rates Higher in the Manchester Lung Health Checks than in the National Lung Screening Trial?

      11:50 - 11:55  |  Presenting Author(s): Hilary A Robbins

      • Abstract

      Loading...

    • +

      MA05.05 - Low-Dose Chest Computed Tomographic Screening and Invasive Diagnosis of Pulmonary Nodules for Lung Cancer in Never-Smokers

      11:55 - 12:00  |  Presenting Author(s): Yeon Wook Kim

      • Abstract

      Loading...

    • +

      MA05.06 - Lung Cancer Screening – Cumulative Results from Five UK-Based Programmes

      12:00 - 12:05  |  Presenting Author(s): Haval Balata

      • Abstract

      Loading...

    • +

      MA05.07 - Discussant

      12:05 - 12:10  |  Presenting Author(s): Stephen Lam

      • Abstract

      Abstract not provided

    • +

      MA05.08 - Impact of Low-Dose CT Screening for Primary Lung Cancer on Subsequent Risk of Brain Metastasis: Secondary Analysis of NLST

      12:10 - 12:15  |  Presenting Author(s): Chloe Chang Su

      • Abstract

      Loading...

    • +

      MA05.09 - Evaluation of Alternative Diagnostic Follow-Up Intervals for Lung-RADs Criteria on the Effectiveness of Lung Cancer Screening 

      12:15 - 12:20  |  Presenting Author(s): Mehrad Bastani

      • Abstract

      Loading...

    • +

      MA05.10 - Performance of Draft 2020 USPSTF Lung-Cancer Screening Guidelines and Potential for use of Risk Models to Reduce Racial/Ethnic Disparities

      12:20 - 12:25  |  Presenting Author(s): Rebecca Landy

      • Abstract

      Loading...

    • +

      MA05.11 - Effect of Lowering the Starting Age for Lung Cancer Screening by Low-Dose Computed Tomography Among Women: A Harm-Benefit Analysis

      12:25 - 12:30  |  Presenting Author(s): Yihui Du

      • Abstract

      Loading...

    • +

      MA05.12 - Discussant

      12:30 - 12:35  |  Presenting Author(s): Hui Zhong Chai

      • Abstract

      Abstract not provided

    • +

      MA05.13 - Live Q&A

      12:35 - 12:45

      • Abstract

      Abstract not provided

  • +

    OA08 - Putting the Patient at the Center: Holistic Patient Care

    • Type: Oral
    • Track: Nursing and Allied Health Professionals
    • +

      OA08.01 - Chair

      11:45 - 11:45  |  Presenting Author(s): Csaba Laszlo Degi

      • Abstract

      Abstract not provided

    • +

      OA08.02 - Chair

      11:45 - 11:45  |  Presenting Author(s): Yeur-Hur Lai

      • Abstract

      Abstract not provided

    • +

      OA08.03 - Joint Modeling of Stress and Survival in Patients with Advanced Non-Small Cell Lung Cancer

      11:45 - 11:55  |  Presenting Author(s): Nicole Andrea Arrato

      • Abstract

      Loading...

    • +

      OA08.04 - Providing Thoracic Prehabilitation during COVID-19: Review of a Virtual Model

      11:55 - 12:05  |  Presenting Author(s): Stephanie Wynne

      • Abstract

      The abstract for this presentation is currently under embargo or has not been submitted.

    • +

      OA08.05 - Illness Perception Profiles at Lung Cancer Diagnosis and Physical and Psychological Symptom Trajectories During Treatment

      12:05 - 12:15  |  Presenting Author(s): Thomas Robert Valentine

      • Abstract

      Loading...

    • +

      OA08.06 - How Complex is Fatigue? Occupational Therapy Playing a Lead Role in Fatigue Management

      12:15 - 12:25  |  Presenting Author(s): Pippa Labuc

      • Abstract

      Loading...

    • +

      OA08.07 - Discussant

      12:25 - 12:35  |  Presenting Author(s): Andreas Charalambous

      • Abstract

      Abstract not provided

    • +

      OA08.08 - Live Q&A

      12:35 - 12:45

      • Abstract

      Abstract not provided

  • +

    IS11 - Industry Symposium Sponsored by Amgen Oncology: Advancing the Next Frontier of Innovation in Lung Cancer Therapies

    • Type: Industry Symposium
    • Track:
    • +

      IS11.01 - Introductions

      13:00 - 13:00

      • Abstract

      Abstract not provided

    • +

      IS11.02 - Current Biomarker Landscape in NSCLC

      13:00 - 13:20  |  Presenting Author(s): Stephen Fox

      • Abstract

      Abstract not provided

    • +

      IS11.03 - Current Unmet Need in KRAS G12C-Mutated NSCLC

      13:20 - 13:40  |  Presenting Author(s): Koichi Goto

      • Abstract

      Abstract not provided

    • +

      IS11.04 - Emerging Novel Targets for Lung Cancer

      13:40 - 14:00  |  Presenting Author(s): Julie Brahmer

      • Abstract

      Abstract not provided